Use of mRNA gene therapy for treating terminal cancer may be one of its few legitimate uses. In this scenario, the risk calculus is dramatically different. You are facing a practical 100% chance of death, so if the treatment has a 5% chance of killing you outright it would still be something to consider.
The use of this technology for a widely distributed therapy to otherwise healthy people is totally different. The level of risk that is acceptable in such a scenario is many orders of magnitude less. mRNA technology is totally unsuitable for any condition that does not entail a significant risk of imminent death.
Use of mRNA gene therapy for treating terminal cancer may be one of its few legitimate uses. In this scenario, the risk calculus is dramatically different. You are facing a practical 100% chance of death, so if the treatment has a 5% chance of killing you outright it would still be something to consider.
The use of this technology for a widely distributed therapy to otherwise healthy people is totally different. The level of risk that is acceptable in such a scenario is many orders of magnitude less. mRNA technology is totally unsuitable for any condition that does not entail a significant risk of imminent death.